![](/img/cover-not-exists.png)
PMS28 - SECUKINUMAB VERSUS INFLIXIMAB IN THE TREATMENT OF PSORIATIC ARTHRITIS: A COST PER RESPONDER ANALYSIS AMONG 48 WEEKS FROM A TUNISIAN PERSPECTIVE.
Yahiaoui, S., Ramakrishna, G.S., Toumi, J., Burke, J., Kooli, A.Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.1742
Date:
October, 2018
File:
PDF, 444 KB
english, 2018